The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.10
Bid: 49.20
Ask: 53.00
Change: 0.00 (0.00%)
Spread: 3.80 (7.724%)
Open: 51.10
High: 51.10
Low: 51.10
Prev. Close: 51.10
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Review of Ogden Discount Rate

2 Mar 2017 14:30

RNS Number : 3824Y
Frenkel Topping Group PLC
02 March 2017
 

Frenkel Topping Group plc

("Frenkel Topping" or the "Company")

Review of Ogden Discount Rate

 

Frenkel Topping (AIM: FEN), a specialist independent financial advisor and asset manager focussed on asset protection for vulnerable clients, provides the following update in relation to the announced change to the discount rate from 2.5% to -0.75% and how it affects the business.

Discount Rate from 2.5% to -0.75%

On the morning of 27 February 2017, the Lord Chancellor ruled that the Ogden discount rate which is used to calculate the damages awarded in clinical negligence and personal injury claims be set at -0.75% rather that the current 2.5%, effective from 20 March 17.

This announcement has dramatically changed how compensation damages are calculated. The last change to the discount rate was in 2001. 

Impact on Damages Award

We are revising the Assets Under Management (AUM) growth assumptions in our business as follows;

Year

Previous Organic Growth Assumption

Revised Organic Growth Assumption

2017

£75m

£100m

2018

£100m

£180m

2019

£100m

£180m

 

Frenkel Topping has calculated that the size of court damages is likely to grow significantly. Using pipeline cases, Frenkel Topping has calculated the following increases as examples:

Quantum @ 2.5% discount rate

Quantum @-0.75% discount rate

Quantum uplift

Claimant Age

Life Expectation

@ 2.5%

@ -0.75%

44

7 year reduction

£ 5,199,736.00

£ 7,640,843.79

47%

57

Normal

£ 3,856,463.00

£ 6,122,055.90

59%

11

Normal

£ 3,619,529.00

£ 6,892,115.39

90%

36

Normal

£ 6,637,936.00

£ 12,596,746.00

90%

13

24 year reduction

£ 9,956,514.00

£ 18,505,359.33

86%

36

Normal

£ 1,784,602.00

£ 3,382,087.37

90%

58

5 year reduction

£ 3,672,383.00

£ 5,545,186.61

51%

8

18 year reduction

£ 5,787,612.00

£ 14,031,550.15

142%

 

Having conducted an analysis over the last 6 months of large loss cases that we have been involved in, the average increase in overall quantum, had the discount rate been -0.75%, is c.80%.

Impact on Periodical Payment Orders (PPO)

A client's decision to receive a PPO instead of a lump sum has been impacted by this change to the discount rate. Claimants who have historically taken a PPO will now favour a lump sum because the peace of mind and diminished need for investment risk, previously only available with a PPO, has in effect been provided within the lump sum. The claimant now not only has a lump sum of damages significantly increased to meet their lifetime needs, but has the added advantage of the flexibility a lump sum award offers.

Clients' desire to take investment risk

With a historic 2.5% discount rate, clients need to take investment risk in order to generate this level of return, net of fees. With a revised -0.75% discount rate, clients' risk appetite is reduced. This is aligned to the ethos of Frenkel Topping's Safety First Portfolios.

Impact to Frenkel Topping

The rate of growth of AUM is expected to accelerate exponentially as a result of clients in receipt of large damage awards.

With larger awards, lower periodical payment orders and a core investment strategy geared towards a lower risk appetite, the market place the company operates within and thus the AUM and profitability of the Company is likely to grow, as shown in the tables below:

Organic AUM growth per annum £'m

Operating profit £'m

Closing AUM £'m

2017

2018

2019

2017

2018

2019

2017

2018

2019

75

100

100

3.40

4.30

5.50

820

920

1,020

100

100

100

3.53

4.55

5.75

845

945

1,045

100

150

150

3.53

4.80

6.50

845

995

1,145

100

200

200

3.53

5.05

7.25

845

1,045

1,245

 

Given our expertise in this market place we recognise that there will be a hiatus in cases settling as court dates will be postponed as lawyers recalculate schedules based on the new discount rate. Therefore the uplift in AUM is expected to flow during H2 2017.

Jason Granite, Executive Chairman said "The changes announced will dramatically increase damages paid to our future clients and as a result, accelerate growth of AUM at Frenkel Topping. The Board is excited at the additional growth prospects this represents.

Higher damages awards will also result in an increase quality of life for those with life changing events outside of their control. As we continue to build higher levels of AUM and drive profitability within the business, we will remain totally focused on supporting clients post settlement for the remainder of their life, delivering excellent customer service and maintaining our 99% client retention rate."

 

For further information:

 

Frenkel Topping Group plc

Jason Granite, Executive Chairman

www.frenkeltopping.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

Julie Dean, Chief Financial Officer

finnCap Ltd

Tel: 020 7220 0500

Adrian Hargrave / James Thompson / Alex Price (Corporate Finance)

Tony Quirke (Corporate Broking)

Walbrook PR Ltd

Tel: 020 7933 8780 or frenkeltopping@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Nick Rome

Mob: 07748 325 236

 

 

About Frenkel Topping: www.frenkeltopping.co.uk

Frenkel Topping provides specialist independent financial advice focussed on asset protection for clients. The specialist independent financial adviser has a market leading position providing advice and fund management services for personal injury trusts and clinical negligence awards and is well placed to provide services to a wider customer base.

The Company provides a range of wealth management services including bespoke investment portfolios, financial and tax planning. It is focused on increasing its assets under management by growing the number of fee earners who are qualified to provide benefits protection for a variety of needs as the Company adds to its personal injury and clinical negligence specialism.

It has a national presence with offices in Manchester, Birmingham, Bristol, Cardiff, London and Leeds and has relationships and infrastructure in place to further grow its reach and target markets.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUAGWUPMGCP
Date   Source Headline
23rd Jun 201411:18 amRNSHolding(s) in Company
2nd Jun 20144:04 pmRNSDirector/PDMR Shareholding
29th May 20149:28 amRNSExercise of Options
14th May 201410:45 amRNSResult of AGM
14th May 20147:00 amRNSAGM Statement
24th Mar 20147:00 amRNSPreliminary Results
24th Feb 201412:16 pmRNSAppointment of Non-Executive Director
20th Feb 20147:00 amRNSNotice of Preliminary Results
20th Jan 20143:33 pmRNSTrading Statement
9th Jan 201412:49 pmRNSNew Director Incentive Scheme
6th Dec 20139:58 amRNSHolding(s) in Company
12th Nov 20133:59 pmRNSHolding(s) in Company
11th Nov 201311:31 amRNSDirector/PDMR Shareholding
26th Sep 20138:51 amRNSHolding(s) in Company
25th Sep 201312:13 pmRNSHolding(s) in Company
6th Sep 20139:26 amRNSHolding(s) in Company
5th Sep 20132:34 pmRNSDirector/PDMR Shareholding
14th Aug 20133:17 pmRNSDirector/PDMR Shareholding - Replacement
14th Aug 20139:44 amRNSDirector/PDMR Shareholding and Group EBT Purchase
6th Aug 20132:28 pmRNSExercise of options
15th Jul 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSNotice of Interim Results
29th May 201310:42 amRNSResult of AGM
29th May 20139:16 amRNSDirector/PDMR Shareholding
29th May 20137:00 amRNSAGM Statement
21st May 20134:10 pmRNSHolding(s) in Company
17th May 20137:00 amRNSHolding(s) in Company
15th May 20133:56 pmRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSPreliminary Results
3rd Apr 20132:57 pmRNSHolding(s) in Company
28th Feb 20137:00 amRNSTotal Voting Rights
12th Feb 20137:00 amRNSAcquisitions of Minority Interests in Subsidiaries
1st Feb 20134:49 pmRNSHolding(s) in Company
1st Feb 20131:54 pmRNSHolding(s) in Company
28th Jan 20137:00 amRNSNotice of Results
16th Jan 20137:00 amRNSTrading Update
30th Nov 20121:26 pmRNSHolding(s) in Company
23rd Oct 201211:23 amRNSDirector's Dealing and Group EBT Share Purchase
4th Oct 20127:00 amRNSFrenkel Topping implements new integrated platform
28th Sep 20127:00 amRNSTotal Voting Rights
10th Sep 201212:53 pmRNSDirector/PDMR Shareholding
29th Aug 201212:00 pmRNSExercise of Options
16th Jul 20127:00 amRNSInterim Results
2nd Jul 20122:07 pmRNSNotice of Interim Results
14th Jun 20126:25 pmRNSDirector/PDMR Shareholding
17th May 201211:55 amRNSResult of AGM
17th May 20127:00 amRNSAGM Statement
4th Apr 20121:42 pmRNSHolding(s) in Company
22nd Mar 20124:52 pmRNSHolding(s) in Company
20th Mar 201210:57 amRNSCalendar for 2011 Final Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.